Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by barcodewhizon Nov 29, 2006 3:11pm
252 Views
Post# 11773172

stuff

stuffIts total human nature to watch every tick and trade, especially when you are WAY OFFSIDE on a stock.. which pretty much everyone is right now. Nobody likes losing money. Lets face it, in retrospect all of us should have sold this on the last spike up to $1.85 ... but who really saw the magnitude of this perfect storm coming ? My take is simple... this situation almost couldnt possibly be uglier.... we are going to have a substantial dilution at close to an all time low... HOWEVER... there is finally value here The technology is maturing into truly marketable and valuable stages... WE WILL FINALLY SEE substantial revenue from our partners and from our various initiatives. This is exactly what the long timers have been waiting for. The ability to finance the various initiatives with generic cash flow as opposed to equity. This is not the time to sell this stock... and those with balls and bullets should be averaging down IMHO
Bullboard Posts